Navigation Links
LCA-Vision to Present at CapStone Investments' 3rd Annual Small-Cap Investor Conference
Date:7/23/2009

CINCINNATI, July 23 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus((R)) brand, today announced that members of its executive management team will present at CapStone Investments' 3rd Annual Small-Cap Investor Conference on Wednesday, July 29, 2009 at 1:30 p.m. Central time (2:30 p.m. Eastern time). The conference is being held at Hyatt Regency Hotel in Milwaukee, Wis. A live and archived webcast of the event will be available at the Investor Relations section of LCA-Vision's website athttp://www.lasikplus.com.

About LCA-Vision Inc./LasikPlus((R))

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus((R)) brand, operates 71 LasikPlus((R)) fixed-site laser vision correction centers in 31 states and 53 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

                        Earning Trust Every Moment.
                                            Transforming Lives Every Day.

For Additional Information

    Company Contact:                        Investor Relations Contact:
    Barb Kise                               Jody Cain
    LCA-Vision Inc.                         Lippert/Heilshorn & Associates
    513-792-9292                            310-691-7100


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. LCA-Vision to Announce Second Quarter 2009 Financial Results on Tuesday, July 28, 2009
2. LCA-Vision Announces Management Changes
3. LCA-Vision Reports on Annual Meeting of Stockholders
4. LCA-Vision Announces First Quarter 2009 Financial Results
5. LCA-Vision to Announce First Quarter 2009 Financial Results on Tuesday, April 28, 2009
6. LCA-Vision Announces Termination of Consent Solicitation and Withdrawal of Dissident Slate of Director Nominees
7. RiskMetrics Affirms Recommendation that Stockholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
8. LCA-Visions Medical Advisory Board Voices Support for Current Management
9. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
10. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
11. The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: